Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	57,792	45,074	43,399	50,869	44,662	56,329
Market Cap Growth	35.85%	3.86%	-14.68%	13.90%	-20.71%	17.61%
Enterprise Value	88,894	78,050	75,918	81,755	74,563	98,218
Last Close Price	18.28	14.61	13.15	15.10	12.65	15.51
PE Ratio	80.24	62.54	45.57	21.33	23.57	16.57
PS Ratio	2.03	1.47	1.54	1.68	1.52	1.95
PB Ratio	1.19	0.97	0.90	1.06	0.95	1.20
P/FCF Ratio	8.76	7.88	12.14	8.08	5.42	6.92
P/OCF Ratio	7.62	6.39	9.16	6.92	4.83	6.16
EV/Sales Ratio	3.12	2.55	2.69	2.70	2.54	3.40
EV/EBITDA Ratio	10.94	9.48	10.04	8.46	7.65	11.04
EV/EBIT Ratio	23.11	20.76	22.99	17.54	15.09	25.62
EV/FCF Ratio	13.47	13.65	21.23	12.99	9.06	12.07
Debt / Equity Ratio	0.71	0.73	0.75	0.77	0.85	0.98
Debt / EBITDA Ratio	4.09	3.96	4.57	3.79	4.07	5.16
Debt / FCF Ratio	5.37	5.94	10.10	5.81	4.81	5.64
Asset Turnover	0.29	0.31	0.29	0.30	0.27	0.25
Inventory Turnover	1.16	1.30	1.30	1.36	1.40	1.34
Quick Ratio	0.54	0.44	0.50	0.49	0.73	1.00
Current Ratio	1.19	1.01	1.11	0.97	1.21	1.53
Return on Equity (ROE)	1.50%	1.52%	2.12%	5.27%	4.24%	7.60%
Return on Assets (ROA)	2.47%	2.40%	2.15%	2.85%	2.88%	2.06%
Return on Invested Capital (ROIC)	2.76%	2.91%	4.35%	5.15%	4.82%	4.50%
Return on Capital Employed (ROCE)	4.70%	4.80%	3.90%	5.40%	5.40%	3.80%
Earnings Yield	1.25%	1.60%	2.20%	4.69%	4.24%	6.04%
FCF Yield	11.42%	12.69%	8.24%	12.37%	18.44%	14.44%
Dividend Yield	2.89%	8.96%	9.45%	8.97%	11.72%	10.49%
Payout Ratio	117.40%	280.28%	199.34%	88.14%	123.30%	75.36%
Buyback Yield / Dilution	-0.25%	-1.58%	-0.67%	0.46%	-0.23%	-0.47%
Total Shareholder Return	2.64%	7.38%	8.78%	9.43%	11.49%	10.02%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q